http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-585833-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d28722ea47feca3df8aff6cabb7f7cf7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D453-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D453-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D453-02
filingDate 2008-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4d1e6f39c2470605c1b09589dc94ac4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3aa35f94323c6b7accef723917b78fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_325f428d0899aa4d7fd166fb179491d9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37c7e5b65e23e081493109cac0db7d42
publicationDate 2011-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NZ-585833-A
titleOfInvention Stable crystalline salt of (r)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabicyclo [2.2.2]oct-yl ester
abstract Disclosed is a D-tartrate salt of compound (1) ((R)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid azabicyclo [2.2.2]oct-3-yl ester) possessing a stoichiometry of 1:1 of D-tartaric acid, and in the form of crystalline ploymorph I, is characterized as in the specification. Also disclosed is the use of said salt in the treatment of incontinence.
priorityDate 2007-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431730204
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448118645
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415789857
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419586128
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID28123
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452672869
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID643460
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422056817
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421719555
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID131730725
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578780
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3386966
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2776954
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID143810949
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2733163
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419488681
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422056819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559577
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID967
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9742
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57503849
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557670
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415967535
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474446
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25147683
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453057672
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21883165
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443400
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451905405
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID55147535
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91404

Total number of triples: 51.